Which three drugs must be reported to the Controlled Substance Monitoring Database (CSMD) if dispensed?

The requirement to report certain medications to the Controlled Substance Monitoring Database (CSMD) is based on their potential for abuse and addiction. In Tennessee, medications that fall under the category of benzodiazepines, barbiturates, and carisoprodol must be reported to the CSMD because they are classified as controlled substances with significant risk for misuse.

Benzodiazepines are commonly prescribed for anxiety and sleep disorders, but they can lead to dependence and have a high potential for abuse. Barbiturates, once commonly used for anxiety and sleep issues, are now less frequently prescribed but still pose substantial risks for addiction and overdose. Carisoprodol, a muscle relaxant, is noted for its potential for abuse, especially in individuals seeking its sedative effects.

Overall, the specific reporting requirement for these drug categories ensures close monitoring of their use and helps prevent prescription drug abuse and diversion within the healthcare system. The other choices either include drugs that do not all meet the monitoring criteria or include classes of medications such as antibiotics, which are not scheduled controlled substances and therefore do not require documentation in the CSMD.